Lutetium Nitrate Solutions are moderate to highly concentrated liquid solutions of Lutetium Nitrate. They are an excellent source of Lutetium Nitrate for applications requiring solubabilzed materials. American Elements can prepare dissolved homogenous solutions at customer specified concentrations or to the maximum stoichiometric concentration. Packaging is available in 55 gallon drums, smaller units and larger liquid totes. American Elements maintains solution production facilities in the United States, Northern Europe (Liverpool, UK), Southern Europe (Milan, Italy), Australia and China to allow for lower freight costs and quicker delivery to our customers .American Elements metal and rare earth compound solutions have numerous applications, but are commonly used in petrochemical cracking and automotive catalysts, water treatment, plating, textiles, research and in optic, laser, crystal and glass applications. Ultra high purity and high purity compositions improve both optical quality and usefulness as scientific standards. Nanoscale (See also Nanotechnology Information and Quantum Dots) elemental powders and suspensions, as alternative high surface area forms, may be considered. We also produce Lutetium Nitrate Powder.American Elements produces to many standard grades when applicable, including Mil Spec (military grade); ACS, Reagent and Technical Grade; Food, Agricultural and Pharmaceutical Grade; Optical Grade, USP and EP/BP (European Pharmacopoeia/British Pharmacopoeia)and follows applicable ASTM testing standards.Typical and custom packaging is available. Additional technical, research and safety (MSDS) information is available as is a Reference Calculator for converting relevant units of measurement.
Lutetium is a Block F, Group 3, Period 6 element. The number of electrons in each of Lutetium's shells is 2, 8, 18, 32, 9, 2 and its electronic configuration is [Xe] 4f15 5d1 6s2. In its elemental form lutetium's CAS number is 7439-94-3. The lutetium atom has a radius of 171.8.pm and it's Van der Waals radius is unknown. Lutetium is not toxic. Lutetium is the last member of the rare earth series. Lutetium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. Unlike most rare earths it lacks a magnetic moment. It also has the smallest metallic radius of any rare earth. It also has the smallest metallic radius of any rare earth. It is perhaps the least naturally abundant of the lanthanides. It is the ideal host for x-ray phosphors because it produces the densest known white material, lutetium tantalate (LuTaO4). It is utilized as a dopant in matching lattice parameters of certain substrate garnet crystals, such as indium-gallium-garnet (IGG) crystals due its lack of a magnetic moment.Lutetium is the last member of the rare earth series. Lutetium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. Unlike most rare earths it lacks a magnetic moment. It also has the smallest metallic radius of any rare earth. Lutetium was first discovered by George Urbain in 1907. The name Lutetium originates from the Latin word Lutetia meaning Paris. See Lutetium research below.
PACKAGING SPECIFICATIONS FOR BULK & RESEARCH QUANTITIES
Typical bulk packaging includes palletized plastic 5 gallon/25 kg. pails, fiber and steel drums to 1 ton super sacks in full container (FCL) or truck load (T/L) quantities. Research and sample quantities and hygroscopic, oxidizing or other air sensitive materials may be packaged under argon or vacuum. Shipping documentation includes a Certificate of Analysis and Material Safety Data Sheet (MSDS). Solutions are packaged in polypropylene, plastic or glass jars up to palletized 440 gallon liquid totes.
Use of internal scintillator radioactivity to calibrate DOI function of a PET detector with a dual-ended-scintillator readout.
Bircher C, Shao Y.
Med Phys. 2012 Feb;39(2):777.
PMID:
22320787
[PubMed - in process]
Phthalocyanine with a giant dielectric constant.
Yazici A, Unüs N, Altindal A, Salih B, Bekaroglu O.
Dalton Trans. 2012 Feb 7. [Epub ahead of print]
PMID:
22310939
[PubMed - as supplied by publisher]
Towards the Real Octupolar Cube: ABAB Bis(phthalocyaninato)lutetium(III) Complex exhibiting Out-standing Quadratic Hyperpolarizability.
Ayhan MM, Singh A, Hirel C, Gürek AG, Ahsen V, Jeanneau E, Ledoux-Rak I, Zyss J, Andraud C, Bretonničre Y.
J Am Chem Soc. 2012 Feb 6. [Epub ahead of print]
PMID:
22308960
[PubMed - as supplied by publisher]
Rare-Earth-Metal-Hydrocarbyl Complexes Bearing Linked Cyclopentadienyl or Fluorenyl Ligands: Synthesis, Catalyzed Styrene Polymerization, and Structure-Reactivity Relationship.
Jian Z, Cui D, Hou Z.
Chemistry. 2012 Jan 26. doi: 10.1002/chem.201102682. [Epub ahead of print]
PMID:
22282393
[PubMed - as supplied by publisher]
Outpatient therapeutic nuclear oncology.
Turner JH.
Ann Nucl Med. 2012 Jan 7. [Epub ahead of print]
PMID:
22222779
[PubMed - as supplied by publisher]
Poly[tetra-aquadi-?(4)-oxalato-lutetium(III)potassium].
Zhang FM, Sun TZ, Hou GF, Yan PF, Li GM.
Acta Crystallogr Sect E Struct Rep Online. 2011 Nov 1;67(Pt 11):m1591. Epub 2011 Oct 22.
PMID:
22219822
[PubMed - in process]
Selected Trace Elements in the Sacramento River, California: Occurrence and Distribution.
Taylor HE, Antweiler RC, Roth DA, Alpers CN, Dileanis P.
Arch Environ Contam Toxicol. 2011 Dec 23. [Epub ahead of print]
PMID:
22193863
[PubMed - as supplied by publisher]
Nuclear chemical transformations of ytterbium and lutetium radionuclides following (n,?) and beta decay reactions in Tris(2,2,6,6-tetramethyle-3,5-heptanedionato)Yb(III).
Nassan L, Achkar B, Yassine T.
Appl Radiat Isot. 2011 Dec 6. [Epub ahead of print]
PMID:
22189373
[PubMed - as supplied by publisher]
Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the (90)Y and (177)Lu labeling conditions.
Asti M, Tegoni M, Farioli D, Iori M, Guidotti C, Cutler CS, Mayer P, Versari A, Salvo D.
Nucl Med Biol. 2011 Dec 13. [Epub ahead of print]
PMID:
22172388
[PubMed - as supplied by publisher]
A novel compensation method for the anode gain non-uniformity of multi-anode photomultiplier tubes.
Lee CM, Il Kwon S, Ko GB, Ito M, Yoon HS, Lee DS, Hong SJ, Lee JS.
Phys Med Biol. 2012 Jan 7;57(1):191-207.
PMID:
22156011
[PubMed - in process]
Automated Module Radiolabeling of Peptides and Antibodies with Gallium-68, Lutetium-177 and Iodine-131.
De Decker M, Turner JH.
Cancer Biother Radiopharm. 2011 Dec 7. [Epub ahead of print]
PMID:
22149590
[PubMed - as supplied by publisher]
An unusual organoyttrium alkyl complex containing a [C5HMe3(?(3)-CH2)-C5H4N-?]- ligand and an elusive cyclopentadienide-based scandium tuck-over zwitterion obtained by C-H bond activation.
Jian Z, Cui D.
Chemistry. 2011 Dec 16;17(51):14578-85. doi: 10.1002/chem.201102378. Epub 2011 Nov 14.
PMID:
22083978
[PubMed - in process]
Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro.
Cescato R, Waser B, Fani M, Reubi JC.
J Nucl Med. 2011 Dec;52(12):1886-90. Epub 2011 Nov 8.
PMID:
22068898
[PubMed - indexed for MEDLINE]
Reactions of late lanthanide metal atoms and methanol in solid argon: a matrix isolation infrared spectroscopic and theoretical study.
Gong Y, Andrews L, Chen M, Dixon DA.
J Phys Chem A. 2011 Dec 29;115(51):14581-92. Epub 2011 Dec 5.
PMID:
22054215
[PubMed - in process]
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Teunissen JJ, Kwekkeboom DJ, Valkema R, Krenning EP.
Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S27-51. Print 2011 Oct. Review.
PMID:
22005114
[PubMed - indexed for MEDLINE]
A Positron Emission Tomograph Based on LSO-APD Modules with a Sampling ADC Read-out System for a Students' Advanced Laboratory Course.
Schneider FR, Mann AB, Konorov I, Delso G, Paul S, Ziegler SI.
Z Med Phys. 2011 Oct 20. [Epub ahead of print]
PMID:
22019183
[PubMed - as supplied by publisher]
Preparation and scintillating properties of sol-gel eu, tb co-doped lu(2)o(3) nanopowders.
de Jesús Morales Ramírez A, Murillo AG, de Jesús Carrillo Romo F, Hernández MG, Palmerin JM, Guerrero RR.
Int J Mol Sci. 2011;12(9):6240-54. Epub 2011 Sep 23.
PMID:
22016655
[PubMed - in process]
Timing and optimized acquisition parameters for the whole-body imaging of š??Lu-EDTMP toward performing bone pain palliation treatment.
Liu C, Brasic JR, Liu X, Li H, Xiang X, Luo Z, Wang Y, Kuai D, Zhang G, Zaknun JJ.
Nucl Med Commun. 2012 Jan;33(1):90-6.
PMID:
22001721
[PubMed - in process]
Physical performance of the new hybrid PET?CT Discovery-690.
Bettinardi V, Presotto L, Rapisarda E, Picchio M, Gianolli L, Gilardi MC.
Med Phys. 2011 Oct;38(10):5394-411.
PMID:
21992359
[PubMed - indexed for MEDLINE]
Dihydrogen addition in a dinuclear rare-earth metal hydride complex supported by a metalated TREN ligand.
Venugopal A, Fegler W, Spaniol TP, Maron L, Okuda J.
J Am Chem Soc. 2011 Nov 9;133(44):17574-7. Epub 2011 Oct 18.